First site initiation for OligoGpivotalCF in Austria

OligoGpivotalCF is about to start! On 6 May 2020 the first site was initiated in Wels, Austria, and more site initiation visits are planned for the coming months. Pending the normalisation of the Covid-19 pandemic, the trial will open for patients at several sites in Europe soon.

To know more, visit

‹ Terug

Contact information

  • Hilde De Keyser
  • 0032 - (0)2 61 32 716
  • Driebruggenstraat 124, 1160 Brussel
  • Chamber of Commerce number: 0640.670.746

Subscribe to newsletter